Insider Buying: Mobia Medical (NASDAQ:MOBI) Insider Buys $20,600.00 in Stock

Mobia Medical, Inc. (NASDAQ:MOBI) insider Chase Leavitt acquired 2,000 shares of Mobia Medical stock in a transaction that occurred on Friday, September 11th. The stock was acquired at an average cost of $10.30 per share, with a total value of $20,600.00. Following the purchase, the insider directly owned 5,000 shares of the company’s stock, valued at $51,500. This represents a 66.67% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Mobia Medical Stock Up 1.4%

Mobia Medical stock opened at $10.86 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28. The stock has a market capitalization of $361.53 million and a price-to-earnings ratio of -0.54. The business’s fifty day moving average is $11.38. Mobia Medical, Inc. has a twelve month low of $9.85 and a twelve month high of $15.29.

Mobia Medical (NASDAQ:MOBI) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The firm had revenue of $13.51 million during the quarter. Mobia Medical’s revenue was up 102.4% on a year-over-year basis. Equities analysts expect that Mobia Medical, Inc. will post -2.63 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have commented on MOBI shares. Weiss Ratings assumed coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating for the company. Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. Bank of America started coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price for the company. Finally, Wolfe Research assumed coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating on the stock. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $20.75.

Institutional Trading of Mobia Medical

An institutional investor recently bought a new position in Mobia Medical stock. Citadel Advisors LLC acquired a new stake in Mobia Medical, Inc. (NASDAQ:MOBI) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 50,000 shares of the company’s stock, valued at approximately $670,000. Citadel Advisors LLC owned about 0.15% of Mobia Medical at the end of the most recent reporting period.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.